Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mertiva AB

www.mertiva.se

Latest From Mertiva AB

Peter Zerhouni new CEO of InDex

InDex Pharmaceuticals has named Peter Zerhouni its new CEO. Mr Zerhouni joins the company, which is developing lead product Kappaproct as a treatment of severe ulcerative colitis, from Diamyd Medical where he was also CEO. He succeeds Jesper Wiklund, who led the company since 2011. 

Gastrointestinal Companies

Deals Shaping The Medical Industry, December 2012

Derived from Strategic Transactions, EBI’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals– and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

A New Collaborative Model? Janssen Joins Evotec And Harvard To Advance Regenerative Diabetes Projects

Germany's drug discovery services company Evotec has formed a tight bond with Harvard researchers, with both parties expected to share the rewards of their CureBeta pancreatic beta-cell regeneration project if new strategic partner Janssen Pharmaceuticals develops new diabetes therapies from their research.

BioPharmaceutical Deals

BioInvent's Tie-Up With Cancer Research Technology Brings Some Relief From Pipeline Setbacks

Sweden's BioInvent forges links with researchers at Queen Mary, University of London, and Cancer Research Technology, the commercial arm of charity Cancer Research UK, to identify new therapeutic antibodies for oncology.

BioPharmaceutical United Kingdom
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Diamyd Medical AB
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Mertiva AB
  • Senior Management
  • Andreas Bergsten, CEO
    Anna Styrud, CFO
    Erika Hillborg, Sr. Dir., Clin. Dev.
  • Contact Info
  • Mertiva AB
    Phone: (46) 8 661 00 26
    Karlavagen 108
    Stockholm, SE-115 26
    Sweden
UsernamePublicRestriction

Register